학술논문

Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor–Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial.
Document Type
Article
Source
Journal of Clinical Oncology; 6/20/2023, Vol. 41 Issue 18, p3329-3338, 10p
Subject
Language
ISSN
0732183X